Latest Health News
Increasing Influenza B Cases in USA
ProMED reports rising Influenza B activity across the United States as of February 14, 2026, marking it as a key alert in ongoing respiratory surveillance. Health officials urge vaccination and monitoring amid seasonal upticks.
Melioidosis Surge in Queensland, Australia
A third update on melioidosis in Queensland highlights ongoing cases of this soil-borne bacterial infection, posing risks in tropical regions. Early detection and antibiotic treatment remain critical.
Measles Outbreak in Armenia
ProMED notes a new measles outbreak in Armenia on February 14, 2026, amid global concerns over vaccination gaps. Public health responses focus on containment and immunization drives.
Cholera Cases Rising Fatally in Mozambique
Increasing cholera cases with fatalities reported in Mozambique as of February 12, 2026, straining local health systems. Improved sanitation and oral rehydration are emphasized in responses.
Lassa Fever Outbreak in Nigeria's Benue State
Ninth report on Lassa fever in Nigeria confirms an outbreak in Benue state on February 12, 2026, a viral hemorrhagic fever endemic to West Africa. Rodent control and PPE use are vital preventive measures.
Hidden Astrocytes Aid Spinal Cord Repair
Cedars-Sinai scientists discovered astrocytes enabling spinal cord repair, potentially treating paralysis, stroke, and multiple sclerosis, announced February 13, 2026. This repair system offers new therapeutic avenues.
Long COVID Linked to Enlarged Choroid Plexus and Alzheimer's Markers
NYU Langone research shows long COVID patients have 10% larger choroid plexus volumes tied to Alzheimer's blood markers and cognitive decline, per February 13, 2026 news. Larger studies are needed for confirmation.
HOXD13 Gene Drives Melanoma Immune Evasion
NYU scientists identified HOXD13 suppressing T-cell responses in melanoma, enabling tumor spread; clinical trials for inhibitors underway, reported February 11-12, 2026. This breakthrough could save thousands of lives.
EB-103 CAR-T Achieves 100% Response in Aggressive NHL
At Tandem 2026, EB-103 CAR-T therapy showed 100% ORR/CR in B-cell NHL with mild side effects, advancing cellular therapy access. Safety-optimized designs reduce severe CRS risks.
KITE-753 Dual CAR-T Excels in Lymphoma with Rapid Manufacturing
KITE-753 dual CD19/CD20 CAR-T yielded 86% ORR and 79% CR in lymphoma, with 13-day production and no severe CRS/ICANS, highlighted at Tandem 2026. This supports real-world implementation.
Global Exposome Forum Panel at AAAS Meeting
A February 14, 2026 panel at AAAS discusses how the human exposome—cumulative environmental exposures—can transform health and medicine via the Global Exposome Forum. Pan-African and UNESCO collaborations advance data synchronization.
US Revokes Greenhouse Gas Endangerment Finding
Trump administration withdrew the 2009 EPA finding linking emissions to public health risks, potentially undermining climate policy as of February 2026 UKHACC bulletin. This raises concerns for health and emission standards.